Impact of influenza vaccination on major cause-specific mortality (Q43176591)

15 November 2017

title

Impact of influenza vaccination on major cause-specific mortality (English)

1 reference

15 November 2017

3

Ching-Te Lai

1 reference

15 November 2017

Chong-Shan Wang

1

1 reference

15 November 2017

Shan-Tair Wang

series ordinal

2

1 reference

15 November 2017

Li-Jen Lin

series ordinal

4

1 reference

15 November 2017

Pesus Chou

series ordinal

5

1 reference

15 November 2017

language of work or name

English

0 references

publication date

25 October 2006

1 reference

15 November 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

15 November 2017

volume

25

1 reference

15 November 2017

issue

7

1 reference

15 November 2017

page(s)

1196-1203

1 reference

The macro-epidemiology of influenza vaccination in 56 countries, 1997--2003.

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Influenza and pneumococcal vaccination of adults aged > or = 65: racial/ethnic differences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Efficacy and cost-effectiveness of influenza vaccination of the elderly in a densely populated and unvaccinated community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Mortality associated with influenza and respiratory syncytial virus in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Reducing major cause-specific hospitalization rates and shortening hospital stays after influenza vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

The impact of influenza epidemics on mortality: introducing a severity index.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Influenza vaccination and the risk of primary cardiac arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Inflammatory responses in influenza A virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Points of control in inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Inflammation in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Taiwan's new national health insurance program: genesis and experience so far.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Acquired disorders of phagocyte function complicating medical and surgical illnesses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Physical inactivity and short-term all-cause mortality in adults with chronic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: clinical and biochemical studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Infection and risk of ischemic stroke: differences among stroke subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Response of C-reactive protein and serum amyloid A to influenza A infection in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

7 January 2021

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Hyperglycemic crises in patients with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Optimizing medical management of patients with pre-end-stage renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Common community respiratory viruses in patients with cancer: more than just "common colds".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

New evidence for stroke prevention: scientific review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Influenza vaccination in elderly patients with advanced colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Acetaminophen, aspirin, and chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Influenza-associated hospitalizations in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

The impact of influenza epidemics on hospitalizations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Hazards of hospitalization of the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

Annual revaccination against influenza and mortality risk in community-dwelling elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.015

10.1016/J.VACCINE.2006.10.015

7 January 2021

Identifiers

DOI

1 reference

release_in5zb7csizhspnzee2d3exhm4y

15 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/in5zb7csizhspnzee2d3exhm4y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference